• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Medtronic-Covidien: What does it mean for medtech? | The week in medtech M&A

Medtronic-Covidien: What does it mean for medtech? | The week in medtech M&A

June 18, 2014 By MassDevice Contributors Network

Analysis: What does the union of Medtronic and Covidien mean for medtech?

June 16, 2014 by MassDevice

Analysis: What does the union of Medtronic and Covidien mean for medtech?

Things got a lot more interesting in the medical device industry over the weekend when news broke Sunday that Medtronic is buying Covidien for a whopping $43 billion.

The union of Medtronic and Covidien, expected to close late this year or early in 2015, would create the world’s largest pure-play medical device company with enough scale to rival Johnson & Johnson’s medtech operation (the combined entity’s annual revenues would be about $27 billion, compared with J&J’s medtech top line of roughly $28 billion). Read more

Blockbuster: Medtronic in $43B deal to acquire Covidien

June 16, 2014 by Brad Perriello

Blockbuster: Medtronic in $43B deal to acquire Covidien

Medtronic said yesterday that it agreed to acquire Covidien in a cash-and-stock deal worth nearly $43 billion.

The buyout, a so-called “inversion” deal, will allow Medtronic to lower its overall tax rate by re-incorporating in Ireland. But Medtronic CEO Omar Ishrak said main drivers were strategic. Read more

Hill-Rom to pay $250M for German OR infrastructure maker

June 16, 2014 by Brad Perriello

Hill-Rom to pay $250M for German OR infrastructure maker

Hill-Rom Holdings said today that it agreed to put up $250 million in cash for the operating room infrastructure arm of Germany’s Trumpf Group.

Trumpf Medical, which makes OR items including surgical tables, surgical lighting and supply units, posted revenues of about $250 million during the last 12 months, according to a press release. Read more

Medtronic's OUS move becomes a political football | MassDevice.com On Call

June 17, 2014 by Arezu Sarvestani

MassDevice.com On Call

MASSDEVICE ON CALL – Medtronic’s acquisition of Covidien has spurred hundreds (if not thousands) of articles, analyses and speculations but at least one political hopeful is using the blockbuster news to gain favor in Medtronic’s home state.

Minnesota Republican and candidate for governor Marty Seifert issued a press release on Sunday blaming the Obama Administration for chasing Medtronic out of the U.S. with the medical device tax. Seifert is running for office against incumbent Mark Dayton (D), who has held the governor’s office since 2011. Read more

Medtronic buyout holds $80M in golden parachutes for Covidien execs

June 17, 2014 by Brad Perriello

Medtronic buyout holds $80M in golden parachutes for Covidien execs

If the top executives at Covidien decide to leave the company after a $43 billion acquisition by Medtronic goes through, they’ll do it under a golden parachute worth a collective $80 million, regulatory filings show.

The top 5 “named executives” at Covidien, led by chairman, president & CEO Joe Almeida, are in line for an average payout of some $16 million if they elect to depart after the deal’s consummation, slated for the end of this year or early next year. Read more

Filed Under: Mergers & Acquisitions, News Well Tagged With: Covidien, Hillrom, Trumpf Medical

More recent news

  • Philips names C-level tech execs, including new chief AI officer role
  • Corcym achieves first-in-human implant of TriMemo for tricuspid valve repair
  • Medtronic veteran joins Teleflex’s board
  • Boston Scientific could miss guidance over cybersecurity incident
  • Abbott earns FDA approval for new dual-energy ablation catheter

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy